Author: Andrew Parker, MD
Andrew Parker, MD
Dr. Andrew Parker is a board-certified internal medicine physician with over 10 years of clinical experience. He earned his medical degree from the University of California, San Francisco (UCSF), and has worked at leading hospitals including St. Mary’s Medical Center. Dr. Parker specializes in patient education and digital health communication. He now focuses on creating clear, accessible, and evidence-based medical content for the public.
Comprehensive Guide to Alemtuzumab: Uses, Dosage, Side Effects, and More What is Alemtuzumab? Alemtuzumab is a monoclonal antibody used to treat specific cancers and autoimmune diseases, primarily chronic lymphocytic leukemia (CLL) and multiple sclerosis (MS). As a humanized anti-CD52 antibody, this drug targets CD52 on the surface of lymphocytes, leading to their depletion and modulation of the immune system. Marketed under brand names like Campath (for CLL) and Lemtrada (for MS), the therapy is administered intravenously and is highly effective in reducing disease activity in relapsing-remitting MS and achieving remission in CLL. The medication’s benefits include prolonged disease control and…